Cargando…
Factors associated with false negative and false positive results of prostate-specific antigen (PSA) and the impact on patient health: Cohort study protocol
INTRODUCTION: Prostate-specific antigen (PSA) is the main tool for early detection, risk stratification and monitoring of prostate cancer (PCa). However, there are controversies about the use of PSA as a population screening test because of the high potential for overdiagnosis and overtreatment asso...
Autores principales: | Bernal-Soriano, Mari Carmen, Parker, Lucy A., López-Garrigos, Maite, Hernández-Aguado, Ildefonso, Caballero-Romeu, Juan P., Gómez-Pérez, Luis, Alfayate-Guerra, Rocío, Pastor-Valero, María, García, Nuria, Lumbreras, Blanca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783167/ https://www.ncbi.nlm.nih.gov/pubmed/31577771 http://dx.doi.org/10.1097/MD.0000000000017451 |
Ejemplares similares
-
Do the Prostate-Specific Antigen (PSA) Tests That Are Ordered in Clinical Practice Adhere to the Pertinent Guidelines?
por: Bernal-Soriano, Mari Carmen, et al.
Publicado: (2021) -
Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data
por: Lumbreras, Blanca, et al.
Publicado: (2022) -
Reply to Jue, J.S.; Alameddine, M. Role of PSA Density and MRI in PSA Interpretation. Comment on “Lumbreras et al. Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data. Cancers 2023, 15, 261”
por: Lumbreras, Blanca, et al.
Publicado: (2023) -
Shared genetic links between bladder cancer and obesity-related traits: A conjunctional false discovery rate study
por: Chen, Jiaqi, et al.
Publicado: (2023) -
Development and validation of a nomogram for predicting prostate cancer in patients with PSA ≤ 20 ng/mL at initial biopsy
por: Wu, Qiang, et al.
Publicado: (2021)